Podinour-XP 562.5mg Injection
Marketer
Nourier Lab
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Podinour-XP 562.5mg Injection
XyloComb 562.5mg injection, a dual-action antibiotic, combats diverse bacterial infections by hindering microbial proliferation and spread. Administration must be solely under a physician's guidance. Complete the prescribed dosage; premature cessation can reduce efficacy. Missed doses should be avoided. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe side effects warrant immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) necessitate emergency care. Inform your doctor of all current medications, including those for pre-existing conditions, especially if pregnant or breastfeeding. Alcohol should be avoided due to potential drowsiness. While generally non-impairing, driving is discouraged if drowsiness or dizziness occur. Adequate rest, balanced nutrition, and sufficient hydration promote recovery. Your doctor may order tests to monitor treatment effectiveness.
Uses of Podinour-XP 562.5mg Injection
Infections caused by bacteria
Major Benefits of Podinour-XP 562.5mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
Common Side effects of Podinour-XP 562.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Podinour-XP 562.5mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Podinour-XP 562.5mg Injection works:
Ceftriaxone and Tazobactum, combined as Podinour-XP 562.5mg Injection, offer targeted antibacterial action. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their survival. Tazobactum's role as a beta-lactamase inhibitor counters bacterial resistance mechanisms, optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside a 562.5mg Podinour-XP injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Podinour-XP 562.5mg is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Podinour-XP 562.5mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Podinour-XP 562.5mg Injection can lead to reduced alertness, visual impairment, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Podinour-XP 562.5mg Injection use in individuals with renal impairment. Seek medical advice.
LiverCAUTION
The 562.5mg Podinour-XP injection requires careful administration to individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alterations for Podinour-XP 562.5mg injection are unnecessary in patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Podinour-XP 562.5mg Injection :
Omitting a scheduled dose of Podinour-XP 562.5mg Injection necessitates contacting your physician.
Facts to Know About Podinour-XP 562.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently